PALMIERI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 3.545
EU - Europa 3.329
AS - Asia 1.098
OC - Oceania 8
SA - Sud America 8
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.990
Nazione #
US - Stati Uniti d'America 3.515
GB - Regno Unito 1.658
CN - Cina 839
IT - Italia 324
SE - Svezia 245
FR - Francia 233
FI - Finlandia 210
IE - Irlanda 196
DE - Germania 182
RU - Federazione Russa 133
SG - Singapore 123
UA - Ucraina 67
TR - Turchia 43
BE - Belgio 34
CA - Canada 25
VN - Vietnam 16
KR - Corea 15
IR - Iran 14
JP - Giappone 14
NL - Olanda 11
IN - India 10
AU - Australia 7
BR - Brasile 6
PL - Polonia 6
ES - Italia 5
MX - Messico 5
SA - Arabia Saudita 5
AT - Austria 4
CZ - Repubblica Ceca 4
TH - Thailandia 4
CH - Svizzera 3
HK - Hong Kong 3
MM - Myanmar 3
AL - Albania 2
BO - Bolivia 2
ID - Indonesia 2
KG - Kirghizistan 2
MD - Moldavia 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.990
Città #
Southend 1.547
Chandler 604
Jacksonville 561
Woodbridge 369
Ann Arbor 343
Houston 210
Dublin 195
Verona 144
Ashburn 143
Beijing 143
Wilmington 120
Nanjing 110
New York 98
Lawrence 86
Princeton 86
Singapore 83
Jinan 75
Helsinki 60
Shenyang 59
Changsha 45
Phoenix 45
Hebei 43
Venice 41
Tianjin 39
Zhengzhou 39
Falls Church 32
Brussels 30
Düsseldorf 30
Haikou 30
Boardman 29
Sindelfingen 27
Jiaxing 25
Ningbo 25
Redmond 24
Nanchang 23
Hangzhou 22
Redwood City 21
Norwalk 20
Milan 19
Taizhou 19
Guangzhou 16
Auburn Hills 15
Augusta 15
Seoul 14
Dallas 13
Los Angeles 13
Seattle 13
Tokyo 13
San Mateo 11
Taiyuan 11
Fairfield 10
Fuzhou 10
Kent 10
Lanzhou 10
San Francisco 10
Dong Ket 9
Philadelphia 9
Toronto 9
Dearborn 8
Mestre 8
Leawood 7
Montréal 7
Ardabil 6
Detroit 6
Elora 6
London 6
San Diego 6
Monmouth Junction 5
Mumbai 5
San Giovanni Ilarione 5
Washington 5
Andover 4
Cleveland 4
Cuauhtémoc 4
Moscow 4
Riyadh 4
Vienna 4
Warsaw 4
Bologna 3
Cambridge 3
Chions 3
Clearwater 3
Edinburgh 3
Ghent 3
Hong Kong 3
Tappahannock 3
Yangon 3
Amsterdam 2
Bishkek 2
Caerano di San Marco 2
Carate Brianza 2
Caserta 2
Chisinau 2
Cooperstown 2
Groningen 2
Kashan 2
Lappeenranta 2
Lissone 2
Madrid 2
Manchester 2
Totale 6.036
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 217
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 160
Secretome protein signature of human pancreatic cancer stem-like cells 159
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 137
Pancreatic cancer stem cells characterization and secretome analysis 135
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 135
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 133
SHOTGUN PROTEOMIC ANALYSIS OF PANCREATIC CANCER STEM CELLS 132
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 126
Protein synthesis inhibitors cycloheximide and anisomycin induce interleukin-6 gene expression and activate transcription factor NF-kappa-B 124
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 122
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 122
Nuclear factor kappa-B (NF-kappa-B), nuclear factor interleukin-6 (NFIL-6 or C/EBP-beta) and nuclear factor interleukin-6-beta (NFIL6-beta or C/EBP-delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell 119
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 119
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 118
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 113
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 111
Cell-specific differences in the regulation of IL-6 expression by PMA 110
Bovine seminal ribonuclease precursor synthesized in vitro 109
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 109
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 108
Regulation of miR-23b expression and its dual role on ROS production and tumour development 107
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 105
Protein-DNA interactions in the 5'-flanking region of the bovine pancreatic ribonuclease gene 104
Nuclear factor kB, nuclear factor interleukin-6 (NFIL6 or C/EBPbeta) and nuclear factor interleukin-6beta (NFIL6beta or C/EBPdelta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6 expressing human breast carcinoma cell line. 104
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 104
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 104
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 103
Qβ DNA-containing hybrid plasmids giving rise to Qβ phage formation in the bacterial host 102
Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways 102
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 101
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 101
Lithostathine messenger RNA expression in different types of chronic pancreatitis. 101
A Qbeta DNA-containing hybrid plasmid giving rise to Qbeta phage formation in the bacterial host [proceedings] 100
How much is secondary structure responsible for resistance of double-stranded RNA to pancreatic ribonuclease A? 99
Expression of opioid genes in bovine seminal vesicles. 97
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 97
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 97
Proteomics in pancreatic cancer research. 97
[Endonucleolytic mechanism of degradation of double-helix RNA by ribonuclease BS-1 and by ribonuclease A aggregates] 96
Repression of the IL-6 gene is associated with hypermethylation. 96
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 96
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells 95
Differential, structure-dependent susceptibily of poli(A) and RNA to monomeric and dimeric pancreatic ribonuclease A. 90
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 90
A pancreatic-like ribonuclease is synthesized in rat brain 89
The differential pattern of tissue specific expression of ruminant pancreatic type ribonucleases may help to understand the evolutionary history of their genes. 88
Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. 87
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 87
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 86
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 86
Sequence analysis of a cloned cDNA coding for bovine seminal ribonuclease 82
The metabolic landscape of cancer stem cells 82
UCP2, a mitochondrial protein regulated at multiple levels 80
In vitro synthesis of pig pancreas ribonuclease. 79
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 78
[Influence of the ionic strength on the effect of monomeric and dimeric RNAse on poly(A)] 77
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 77
GAAP-1: A transcriptional activator of p53 and IRF-1 possesses pro-apoptotic activity 76
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 75
Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. 74
Genomic footprinting: detection of putative regulatory proteins in the promoter region of the interferon-alpha-1 gene in normal human tissues. 73
Sequences related to the ox pancreatic ribonuclease coding region in the genomic DNA of mammalian species 73
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 72
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 71
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 71
[Structure-dependent differential susceptibility of poly(A) to pancreatic ribonuclease and to ribonuclease BS-1] 70
[Relationship between the basicity of the ribonuclease molecule and the degradation of double spiral RNA: recent contribution] 70
Molecular cloning of the gene encoding the bovine brain ribonuclease and its expression in different regions of the brain. 70
Extracellular Matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome 70
Oncometabolites in cancer aggressiveness and tumour repopulation 68
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 66
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 65
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 64
Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB 63
Progressively de-differentiated pancreatic cancer cells shift from glycolysis to oxidative metabolism and gain a quiescent stem state 62
Structure of the bovine pancreatic ribonuclease gene: the unique intervening sequence in the 5' untraslated region contains a promoter-like element. 61
Molecular evolution of genes encoding ribonucleases in ruminant species. 59
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 58
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 55
Interaction of the nuclear protein CBF1 with the kB site of the IL-6 gene promoter. 54
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 54
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate‑copper complex loaded into hyaluronic acid decorated liposomes 54
Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development 52
Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells 51
Mitochondrial Elongation and OPA1 Play Crucial Roles during the Stemness Acquisition Process in Pancreatic Ductal Adenocarcinoma 45
Regulation of succinate dehydrogenase and role of succinate in cancer 42
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells 18
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 16
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 15
Totale 8.071
Categoria #
all - tutte 24.862
article - articoli 22.916
book - libri 0
conference - conferenze 1.946
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020757 0 0 5 71 147 112 59 74 48 97 52 92
2020/2021895 165 121 30 83 87 93 16 62 64 8 132 34
2021/2022810 109 173 18 59 36 26 31 42 33 20 79 184
2022/20231.685 122 182 143 315 152 341 25 111 190 54 34 16
2023/2024723 31 77 46 98 90 150 18 47 9 34 98 25
2024/2025250 85 139 26 0 0 0 0 0 0 0 0 0
Totale 8.071